Global Healthcare CMO 麻豆原创 Research Report 2023

Publication ID:

PB502236570

Publication Date:

February 7, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Industry and government regulations have forced enterprises to outsource manufacturing operations to the third party to remain competitive and enhance business process efficiency. Increasing investment in the healthcare sector has also provided the necessary impetus to the market.
Highlights
The global Healthcare CMO market was valued at US$ 91100 million in 2022 and is anticipated to reach US$ 160510 million by 2029, witnessing a CAGR of 9.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Healthcare CMO is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Healthcare CMO is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Healthcare CMO in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Healthcare CMO include Accellent, Boehringer Ingelheim, Catalent, DSM, Fareva, Greatbatch, Lonza, Patheon and Piramal, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Healthcare CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare CMO.
The Healthcare CMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Healthcare CMO market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Healthcare CMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Accellent
Boehringer Ingelheim
Catalent
DSM
Fareva
Greatbatch
Lonza
Patheon
Piramal
Tecomet
Segment by Type
Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, and Packaging)
Medical Device Contract Manufacturing Services (Outsourcing Design, Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products), and Final Goods Assembly)
Final Goods Assembly
Segment by Application
Pharmaceutical
Biotechnology Industry
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Healthcare CMO companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Healthcare CMO 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, and Packaging)
1.2.3 Medical Device Contract Manufacturing Services (Outsourcing Design, Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products), and Final Goods Assembly)
1.2.4 Final Goods Assembly
1.3 麻豆原创 by Application
1.3.1 Global Healthcare CMO 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Biotechnology Industry
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Healthcare CMO 麻豆原创 Perspective (2018-2029)
2.2 Healthcare CMO Growth Trends by Region
2.2.1 Global Healthcare CMO 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Healthcare CMO Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Healthcare CMO Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Healthcare CMO 麻豆原创 Dynamics
2.3.1 Healthcare CMO Industry Trends
2.3.2 Healthcare CMO 麻豆原创 Drivers
2.3.3 Healthcare CMO 麻豆原创 Challenges
2.3.4 Healthcare CMO 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare CMO Players by Revenue
3.1.1 Global Top Healthcare CMO Players by Revenue (2018-2023)
3.1.2 Global Healthcare CMO Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Healthcare CMO 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Healthcare CMO Revenue
3.4 Global Healthcare CMO 麻豆原创 Concentration Ratio
3.4.1 Global Healthcare CMO 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare CMO Revenue in 2022
3.5 Healthcare CMO Key Players Head office and Area Served
3.6 Key Players Healthcare CMO Product Solution and Service
3.7 Date of Enter into Healthcare CMO 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare CMO Breakdown Data by Type
4.1 Global Healthcare CMO Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Healthcare CMO Forecasted 麻豆原创 Size by Type (2024-2029)
5 Healthcare CMO Breakdown Data by Application
5.1 Global Healthcare CMO Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Healthcare CMO Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Healthcare CMO 麻豆原创 Size (2018-2029)
6.2 North America Healthcare CMO 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Healthcare CMO 麻豆原创 Size by Country (2018-2023)
6.4 North America Healthcare CMO 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Healthcare CMO 麻豆原创 Size (2018-2029)
7.2 Europe Healthcare CMO 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Healthcare CMO 麻豆原创 Size by Country (2018-2023)
7.4 Europe Healthcare CMO 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Healthcare CMO 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Healthcare CMO 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Healthcare CMO 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Healthcare CMO 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Healthcare CMO 麻豆原创 Size (2018-2029)
9.2 Latin America Healthcare CMO 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Healthcare CMO 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Healthcare CMO 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare CMO 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Healthcare CMO 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Healthcare CMO 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Healthcare CMO 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Accellent
11.1.1 Accellent Company Detail
11.1.2 Accellent Business Overview
11.1.3 Accellent Healthcare CMO Introduction
11.1.4 Accellent Revenue in Healthcare CMO Business (2018-2023)
11.1.5 Accellent Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Healthcare CMO Introduction
11.2.4 Boehringer Ingelheim Revenue in Healthcare CMO Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Catalent
11.3.1 Catalent Company Detail
11.3.2 Catalent Business Overview
11.3.3 Catalent Healthcare CMO Introduction
11.3.4 Catalent Revenue in Healthcare CMO Business (2018-2023)
11.3.5 Catalent Recent Development
11.4 DSM
11.4.1 DSM Company Detail
11.4.2 DSM Business Overview
11.4.3 DSM Healthcare CMO Introduction
11.4.4 DSM Revenue in Healthcare CMO Business (2018-2023)
11.4.5 DSM Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Healthcare CMO Introduction
11.5.4 Fareva Revenue in Healthcare CMO Business (2018-2023)
11.5.5 Fareva Recent Development
11.6 Greatbatch
11.6.1 Greatbatch Company Detail
11.6.2 Greatbatch Business Overview
11.6.3 Greatbatch Healthcare CMO Introduction
11.6.4 Greatbatch Revenue in Healthcare CMO Business (2018-2023)
11.6.5 Greatbatch Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza Healthcare CMO Introduction
11.7.4 Lonza Revenue in Healthcare CMO Business (2018-2023)
11.7.5 Lonza Recent Development
11.8 Patheon
11.8.1 Patheon Company Detail
11.8.2 Patheon Business Overview
11.8.3 Patheon Healthcare CMO Introduction
11.8.4 Patheon Revenue in Healthcare CMO Business (2018-2023)
11.8.5 Patheon Recent Development
11.9 Piramal
11.9.1 Piramal Company Detail
11.9.2 Piramal Business Overview
11.9.3 Piramal Healthcare CMO Introduction
11.9.4 Piramal Revenue in Healthcare CMO Business (2018-2023)
11.9.5 Piramal Recent Development
11.10 Tecomet
11.10.1 Tecomet Company Detail
11.10.2 Tecomet Business Overview
11.10.3 Tecomet Healthcare CMO Introduction
11.10.4 Tecomet Revenue in Healthcare CMO Business (2018-2023)
11.10.5 Tecomet Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Accellent
Boehringer Ingelheim
Catalent
DSM
Fareva
Greatbatch
Lonza
Patheon
Piramal
Tecomet

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.